First Light Asset Management LLC Decreases Holdings in Oscar Health, Inc. (NYSE:OSCR)

First Light Asset Management LLC lowered its position in Oscar Health, Inc. (NYSE:OSCR) by 11.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,865,922 shares of the company’s stock after selling 236,632 shares during the quarter. Oscar Health makes up approximately 2.6% of First Light Asset Management LLC’s portfolio, making the stock its 19th biggest position. First Light Asset Management LLC’s holdings in Oscar Health were worth $29,519,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. American International Group Inc. grew its stake in shares of Oscar Health by 1.3% during the first quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after buying an additional 1,009 shares during the last quarter. Summit Trail Advisors LLC boosted its holdings in Oscar Health by 5.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after acquiring an additional 1,065 shares during the period. Arizona State Retirement System grew its position in Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock worth $602,000 after acquiring an additional 1,351 shares during the last quarter. Amalgamated Bank increased its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the period. Finally, ProShare Advisors LLC lifted its position in Oscar Health by 10.9% in the first quarter. ProShare Advisors LLC now owns 28,950 shares of the company’s stock valued at $430,000 after purchasing an additional 2,842 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on OSCR. Baird R W upgraded shares of Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Robert W. Baird assumed coverage on shares of Oscar Health in a research report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price objective on the stock. Piper Sandler reiterated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America restated a “neutral” rating and set a $21.00 price target (down previously from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Finally, Wells Fargo & Company increased their price objective on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $24.17.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $22.33 on Tuesday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The company has a 50 day simple moving average of $18.03 and a two-hundred day simple moving average of $17.65. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $23.79. The company has a market capitalization of $5.40 billion, a price-to-earnings ratio of -55.82, a P/E/G ratio of 43.42 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. During the same quarter last year, the company earned ($0.07) EPS. The firm’s revenue for the quarter was up 44.6% on a year-over-year basis. Analysts expect that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Insider Activity

In related news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at $2,530,257.52. The disclosure for this sale can be found here. Insiders sold 169,569 shares of company stock worth $3,007,069 over the last three months. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.